Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas: A Sarah Cannon Research Institute phase II trial

Objectives: To evaluate the 6-mo overall survival, safety and tolerability of lenalidomide in combination with standard gemcitabine as first-line treatment for patients with metastatic pancreatic cancer. Methods: Eligibility included: previously untreated metastatic adenocarcinoma of the pancreas wi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Infante, Jeffrey R., Arkenau, Hendrik-Tobias, Bendell, Johanna C., Rubin, Mark S., Waterhouse, David, Jones, George Tripp, Spigel, David R., Lane, Cassie M., Hainsworth, John D., Burris III, Howard A.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Landes Bioscience 2013
विषय:
Research Paper
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3667874/
https://ncbi.nlm.nih.gov/pubmed/23358470
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.23625
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन